Showing all 3 results
Ethinylestradiol & Levonorgestrel Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant “Calendar Blister” packs to ensure absolute daily patient compliance and chemical stability.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.03 mg (30 mcg) The Estrogenic Anchor: The synthetic estrogen required to suppress FSH release and stabilize the uterine lining to prevent irregular breakthrough bleeding. Levonorgestrel USP/Ph.Eur. 0.15 mg (150 mcg) The Progestin Powerhouse: The highly potent, second-generation progestin required to suppress the LH surge and thicken the cervical mucus. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Sugar/Film Coating Diluent / Disintegrant / High-Shear Binder / Lubricant (Engineered specifically using elite multi-stage geometric dilution to guarantee the microscopic 30 mcg and 150 mcg payloads are flawlessly distributed, preventing lethal hormonal drops that cause contraceptive failure) *Pack Sizes: 21-Day Active Blisters OR 28-Day Calendar Blisters (21 Active Hormonal Tablets + 7 Placebo/Iron Tablets to enforce daily habit-forming compliance).
Letrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Metformin Tablet
FreeProduct Composition & Portfolio Range
We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride IP / BP / USP 500 mg Hydrophilic Dual-Polymer Sustained-Release Initial Titration: For low-dose introductory management and early-stage Type 2 stabilization. Metformin Hydrochloride IP / BP / USP 750 mg Hydrophilic Dual-Polymer Sustained-Release Intermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count. Metformin Hydrochloride IP / BP / USP 1000 mg Hydrophilic Dual-Polymer Sustained-Release High-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format.
